Environmental

NVCR’s high R&D intensity supports product innovation with limited direct environmental exposure, but peers in medtech often show similar low-operational-footprint profiles.

The company’s asset-light model likely constrains manufacturing emissions relative to vertically integrated peers, yet disclosed environmental metrics remain limited versus better-reporting competitors.

No material environmental controversies are evident in the provided data, but the absence of granular emissions, energy, and waste disclosure weakens peer transparency.

Environmental risk appears more indirect through supply-chain and product lifecycle expectations, which are material across the sector but not shown as a clear differentiator here.

Social

NVCR’s high R&D spend indicates sustained investment in patient-facing innovation, but peers with broader clinical evidence bases may demonstrate stronger social credibility.

Stock-based compensation at 15.6% of revenue can support talent retention, though it may also signal heavier reliance on equity incentives than some peers.

The provided data do not show workforce, safety, or access-to-care metrics, leaving social positioning broadly average versus better-disclosed medtech peers.

As a healthcare technology company, product quality and patient outcomes are material social factors, but no peer-leading evidence is available in the supplied metrics.

Governance

Debt-to-equity of 0.69 and net debt-to-EBITDA of -1.04 suggest a manageable balance-sheet profile, but governance strength depends more on disclosure and oversight than leverage alone.

Stock-based compensation at 15.6% of revenue is meaningful and can dilute alignment if not tightly governed, especially versus peers with lower equity compensation intensity.

The absence of filing-based board, audit, and shareholder-rights details limits confidence in governance relative to peers with more transparent controls and disclosures.

High gross margin supports internal discipline, yet the provided metrics do not evidence superior governance practices compared with stronger-disclosing medtech peers.

Overall Score

NVCR appears broadly average versus peers on ESG, with limited disclosed controversies but insufficient evidence of standout environmental, social, or governance leadership.

Score Driver: Limited Peer-Differentiating ESG Disclosure Across All Three Pillars